MedPath

Comparison of the effectiveness of tDCS, ACT and their combined effect on negative emotion, impulsiveness, perceived stress, cortisol? and estrogen levels in patients with migraine

Not Applicable
Conditions
Migraine headaches.
Registration Number
IRCT20220511054824N1
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
120
Inclusion Criteria

Taking confirmed diagnosis of migraine, signing the written consent, Proficiency in Persian language, having access to the Internet and the Skype software (for groups taking the ACT course), being between the ages of 20 and 40, having no other effective physical or psychological conditions, and not undergoing drug and other treatments

Exclusion Criteria

Receiving another treatment during the intervention, having a history of a serious medical or neurological disorder (for participants who received tDCS), such as multiple sclerosis, brain injury or tumors, Parkinson’s disease, seizures, dementia, brain stroke or any kind of heart disease, Huntington’s chorea, having cardiac pacemaker, having any metal objects in or near the head, and implanted medication pumps which would increase the risk of tDCS

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
egative emotion, impulsiveness, perceived stress, blood cortisol and estrogen levels. Timepoint: Before the start of the intervention, after the end of the intervention and three months after the end of the intervention. Method of measurement: Positive and negative affect scale (PANAS), Barratt impulsiveness scale (BIS), Perceived stress scale (PSS), Blood test to measure cortisol and estrogen levels.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath